Genome and transcriptome profiles of CD133-positive colorectal cancer cells

American Journal of Pathology

Volumn 178, Issue 4, 2011, Pages 1478-1488

  Gaiser, Timo ^a   Camps, Jordi ^a   Meinhardt, Sandra ^a   Wangsa, Danny ^a   Nguyen, Quang Tri ^a   Varma, Sudhir ^b   Dittfeld, Claudia ^c   Kunz Schughart, Leoni A ^c   Kemmerling, Ralf ^d   Becker, Maria R ^a   Heselmeyer Haddad, Kerstin ^a   Ried, Thomas ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^d PARACELSUS MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; TRANSCRIPTOME;

ANIMAL MODEL; ARRAY COMPARATIVE GENOMIC HYBRIDIZATION; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER GENETICS; CANCER STEM CELL; CARCINOGENICITY; CELL COMPARTMENTALIZATION; CELL FRACTIONATION; CELL POPULATION; CELL PROLIFERATION; CELL SELECTION; COLORECTAL CANCER; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INJECTION; LASER CAPTURE MICRODISSECTION; MOUSE; NONHUMAN; PRIMARY TUMOR; PRIORITY JOURNAL; TRANSCRIPTOMICS; TUMOR VOLUME; TUMOR XENOGRAFT;

EID: 79953668083     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2010.12.036     Document Type: Article

References (62)

1. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 2000, 100:57-70 (Pubitemid 30046295)
2. Leslie A, Carey FA, Pratt NR, Steele RJ: The colorectal adenomacarcinoma sequence. Br J Surg 2002, 89:845-860
3. Habermann JK, Paulsen U, Roblick UJ, Upender MB, McShane LM, Korn EL, Wangsa D, Kruger S, Duchrow M, Bruch HP, Auer G, Ried T: Stage-specific alterations of the genome, transcriptome, and proteome during colorectal carcinogenesis. Genes Chromosomes Cancer 2007, 46:10-26 (Pubitemid 44772868)
4. Ried T, Knutzen R, Steinbeck R, Blegen H, Schrock E, Heselmeyer K, du Manoir S, Auer G: Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosomes Cancer 1996, 15:234-245
5. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL: Genetic alterations during colorectal-tumor development. N Engl J Med 1988, 319:525-532
6. Wicha MS, Liu S, Dontu G: Cancer stem cells: an old idea-a paradigm shift, Cancer Res 2006, 66:1883-1890; discussion 1895-1886
7. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA, Dick JE: A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994, 367:645-648 (Pubitemid 24067706)
8. Wang S, Garcia AJ, Wu M, Lawson DA, Witte ON, Wu H: Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation, Proc Natl Acad Sci USA 2006, 103:1480-1485 (Pubitemid 43191191)
9. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF: Prospective identification of tumorigenic breast cancer cells, Proc Natl Acad Sci USA 2003, 100:3983-3988 (Pubitemid 36418143)
10. Polyak K: Breast cancer: origins and evolution. J Clin Invest 2007, 117:3155-3163
11. Stingl J, Caldas C: Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis. Nat Rev Cancer 2007, 7:791-799 (Pubitemid 47463670)
12. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, Dirks PB: Identification of a cancer stem cell in human brain tumors. Cancer Res 2003, 63:5821-5828 (Pubitemid 37187480)
13. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB: Identification of human brain tumour initiating cells. Nature 2004, 432:396-401 (Pubitemid 39551674)
14. Jordan CT: Cancer stem cell biology: from leukemia to solid tumors. Curr Opin Cell Biol 2004, 16:708-712
15. O'Brien CA, Kreso A, Dick JE: Cancer stem cells in solid tumors: an overview. Semin Radiat Oncol 2009, 19:71-77
16. Visvader JE, Lindeman GJ: Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 2008, 8:755-768
17. Mizrak D, Brittan M, Alison MR: CD133: molecule of the moment. J Pathol 2008, 214:3-9
18. Ferrandina G, Petrillo M, Bonanno G, Scambia G: Targeting CD133 antigen in cancer. Expert Opin Ther Targets 2009, 13:823-837
19. Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, Leary AG, Olweus J, Kearney J, Buck DW: AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997, 90:5002-5012 (Pubitemid 28007217)
20. Bertolini G, Roz L, Perego P, Tortoreto M, Fontanella E, Gatti L, Pratesi G, Fabbri A, Andriani F, Tinelli S, Roz E, Caserini R, Lo Vullo S, Camerini T, Mariani L, Delia D, Calabro E, Pastorino U, Sozzi G: Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment, Proc Natl Acad Sci USA 2009, 106:16281-16286
21. Immervoll H, Hoem D, Sakariassen PO, Steffensen OJ, Molven A: Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas, BMC Cancer 2008, 8:48
22. Wright MH, Calcagno AM, Salcido CD, Carlson MD, Ambudkar SV, Varticovski L: Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics. Breast Cancer Res 2008, 10:R10
23. Maw MA, Corbeil D, Koch J, Hellwig A, Wilson-Wheeler JC, Bridges RJ, Kumaramanickavel G, John S, Nancarrow D, Roper K, Weigmann A, Huttner WB, Denton MJ: A frameshift mutation in prominin (mouse)-like 1 causes human retinal degeneration. Hum Mol Genet 2000, 9:27-34 (Pubitemid 30145285)
24. Corbeil D, Roper K, Fargeas CA, Joester A, Huttner WB: Prominin: a story of cholesterol, plasma membrane protrusions and human pathology. Traffic 2001, 2:82-91 (Pubitemid 32219860)
25. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, De Maria R: Identification and expansion of human colon-cancerinitiating cells. Nature 2007, 445:111-115 (Pubitemid 46067311)
26. O'Brien CA, Pollett A, Gallinger S, Dick JE: A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007, 445:106-110 (Pubitemid 46067310)
27. Shmelkov SV, Butler JM, Hooper AT, Hormigo A, Kushner J, Milde T, St Clair R, Baljevic M, White I, Jin DK, Chadburn A, Murphy AJ, Valenzuela DM, Gale NW, Thurston G, Yancopoulos GD, D'Angelica M, Kemeny N, Lyden D, Rafii S: CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. J Clin Invest 2008, 118:2111-2120 (Pubitemid 351872330)
28. Wu Y, Wu PY: CD133 as a marker for cancer stem cells: progresses and concerns. Stem Cells Dev 2009, 18:1127-1134
29. LaBarge MA, Bissell MJ: Is CD133 a marker of metastatic colon cancer stem cells? J Clin Invest 2008, 118:2021-2024
30. Jungblut M, Oeltze K, Zehnter I, Hasselmann D, Bosio A: Standardized Preparation of Single-Cell Suspensions from Mouse Lung Tissue using the gentleMACS Dissociator, J Vis Exp 2009, e1266
31. Dittfeld C, Dietrich A, Peickert S, Hering S, Baumann M, Grade M, Ried T, Kunz-Schughart LA: CD133 expression is not selective for tumor-initiating or radioresistant cell populations in the CRC cell lines HCT-116. Radiother Oncol 2009, 92:353-361
32. du Manoir S, Speicher MR, Joos S, Schrock E, Popp S, Dohner H, Kovacs G, Robert-Nicoud M, Lichter P, Cremer T: Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization. Hum Genet 1993, 90:590-610
33. Euhus DM, Hudd C, LaRegina MC, Johnson FE: Tumor measurement in the nude mouse. J Surg Oncol 1986, 31:229-234 (Pubitemid 16104025)
34. Benjamini Y, Hochberg Y: Controlling the False Discovery Rate: a Practical and Powerful Approach to Multiple Testing. J R Stat Soc Series B Stat Methodol 1995, 57:289-300
35. Horst D, Kriegl L, Engel J, Kirchner T, Jung A: CD133 expression is an independent prognostic marker for low survival in colorectal cancer. Br J Cancer 2008, 99:1285-1289
36. Corbeil D, Roper K, Hellwig A, Tavian M, Miraglia S, Watt SM, Simmons PJ, Peault B, Buck DW, Huttner WB: The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions. J Biol Chem 2000, 275:5512-5520 (Pubitemid 30115186)
37. Florek M, Haase M, Marzesco AM, Freund D, Ehninger G, Huttner WB, Corbeil D: Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancer. Cell Tissue Res 2005, 319:15-26 (Pubitemid 40104635)
38. Rousset M, Dussaulx E, Chevalier G, Zweibaum A: Growth-related glycogen levels of human intestine carcinoma cell lines grown in vitro and in vivo in nude mice. J Natl Cancer Inst 1980, 65:885-889 (Pubitemid 11215013)
39. Kawamoto H, Yuasa T, Kubota Y, Seita M, Sasamoto H, Shahid JM, Hayashi T, Nakahara H, Hassan R, Iwamuro M, Kondo E, Nakaji S, Tanaka N, Kobayashi N: Characteristics of CD133(+) human colon cancer SW620 cells. Cell Transplant 2010, 19:857-864
40. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ: Cancer statistics, 2009. CA Cancer J Clin 2009, 59:225-249
41. Holzel D, Eckel R, Engel J: [Colorectal cancer metastasis. Frequency, prognosis, and consequences]. Chirurg 2009, 80:331-340
42. O'Connell JB, Maggard MA, Ko CY: Colon cancer survival rates with the new American Joint Committee on Cancer ed 4 staging. J Natl Cancer Inst 2004, 96:1420-1425 (Pubitemid 39429665)
43. Saigusa S, Tanaka K, Toiyama Y, Yokoe T, Okugawa Y, Ioue Y, Miki C, Kusunoki M: Correlation of CD133. OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy, Ann Surg Oncol 2009, 16:3488-3498
44. Sussman RT, Ricci MS, Hart LS, Sun SY, El-Deiry WS: Chemotherapyresistant side-population of colon cancer cells has a higher sensitivity to TRAIL than the non-SP, a higher expression of c-Myc and TRAILreceptor DR4. Cancer Biol Ther 2007, 6:1490-1495 (Pubitemid 351590363)
45. Todaro M, Alea MP, Di Stefano AB, Cammareri P, Vermeulen L, Iovino F, Tripodo C, Russo A, Gulotta G, Medema JP, Stassi G: Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 2007, 1:389-402 (Pubitemid 47506537)
46. Dean M, Fojo T, Bates S: Tumour stem cells and drug resistance. Nat Rev Cancer 2005, 5:275-284 (Pubitemid 40488633)
47. Murat A, Migliavacca E, Gorlia T, Lambiv WL, Shay T, Hamou MF, de Tribolet N, Regli L, Wick W, Kouwenhoven MC, Hainfellner JA, Heppner FL, Dietrich PY, Zimmer Y, Cairncross JG, Janzer RC, Domany E, Delorenzi M, Stupp R, Hegi ME: Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. J Clin Oncol 2008, 26:3015-3024
48. Todaro M, Lombardo Y, Francipane MG, Alea MP, Cammareri P, Iovino F, Di Stefano AB, Di Bernardo C, Agrusa A, Condorelli G, Walczak H, Stassi G: Apoptosis resistance in epithelial tumors is mediated by tumor-cell-derived interleukin-4. Cell Death Differ 2008, 15:762-772 (Pubitemid 351405081)
49. Todaro M, Perez Alea M, Scopelliti A, Medema JP, Stassi G: IL-4-mediated drug resistance in colon cancer stem cells. Cell Cycle 2008, 7:309-313 (Pubitemid 351366493)
50. Yasuda H, Tanaka K, Saigusa S, Toiyama Y, Koike Y, Okugawa Y, Yokoe T, Kawamoto A, Inoue Y, Miki C, Kusunoki M: Elevated CD133, but not VEGF or EGFR, as a predictive marker of distant recurrence after preoperative chemoradiotherapy in rectal cancer. Oncol Rep 2009, 22:709-717
51. Peng J, Lu JJ, Zhu J, Xu Y, Lu H, Lian P, Cai G, Cai S: Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer, Cancer J 2008, 14:54-61
52. Horst D, Scheel SK, Liebmann S, Neumann J, Maatz S, Kirchner T, Jung A: The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer. J Pathol 2009, 219:427-434
53. Reya T, Morrison SJ, Clarke MF, Weissman IL: Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111 (Pubitemid 33041634)
54. Ieta K, Tanaka F, Haraguchi N, Kita Y, Sakashita H, Mimori K, Matsumoto T, Inoue H, Kuwano H, Mori M: Biological and genetic characteristics of tumor-initiating cells in colon cancer. Ann Surg Oncol 2008, 15:638-648 (Pubitemid 351643025)
55. Corbeil D, Marzesco AM, Fargeas CA, Huttner WB: Prominin-1: a distinct cholesterol-binding membrane protein and the organisation of the apical plasma membrane of epithelial cells. Subcell Biochem 2010, 51:399-423
56. Corbeil D, Marzesco AM, Wilsch-Brauninger M, Huttner WB: The intriguing links between prominin-1 (CD133), cholesterol-based membrane microdomains, remodeling of apical plasma membrane protrusions, extracellular membrane particles, and (neuro)epithelial cell differentiation. FEBS Lett 2010, 584:1659-1664
57. Florek M, Bauer N, Janich P, Wilsch-Braeuninger M, Fargeas CA, Marzesco AM, Ehninger G, Thiele C, Huttner WB, Corbeil D: Prominin-2 is a cholesterol-binding protein associated with apical and basolateral plasmalemmal protrusions in polarized epithelial cells and released into urine. Cell Tissue Res 2007, 328:31-47 (Pubitemid 46411908)
58. Grade M, Becker H, Liersch T, Ried T, Ghadimi BM: Molecular cytogenetics: genomic imbalances in colorectal cancer and their clinical impact. Cell Oncol 2006, 28:71-84 (Pubitemid 43999883)
59. Navin N, Krasnitz A, Rodgers L, Cook K, Meth J, Kendall J, Riggs M, Eberling Y, Troge J, Grubor V, Levy D, Lundin P, Maner S, Zetterberg A, Hicks J, Wigler M: Inferring tumor progression from genomic heterogeneity. Genome Res 2010, 20:68-80
60. Hermsen M, Postma C, Baak J, Weiss M, Rapallo A, Sciutto A, Roemen G, Arends JW, Williams R, Giaretti W, De Goeij A, Meijer G: Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability. Gastroenterology 2002, 123:1109-1119
61. Neklason DW, Tuohy TM, Stevens J, Otterud B, Baird L, Kerber RA, Samowitz WS, Kuwada SK, Leppert MF, Burt RW: Colorectal adenomas and cancer link to chromosome 13q22.1-13q31.3 in a large family with excess colorectal cancer. J Med Genet 2010, 47:692-699
62. Diosdado B, van de Wiel MA, Terhaar Sive Droste JS, Mongera S, Postma C, Meijerink WJ, Carvalho B, Meijer GA: MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression. Br J Cancer 2009, 101:707-714